Prevalence of antimicrobial drug-resistant Streptococcus pneumoniae in Washington State

Western Journal of Medicine

Volumn 169, Issue 6, 1998, Pages 364-369

  Frick, Pamela A ^a   Black, Douglas J ^a   Duchin, Jeffrey S ^b   Deliganis, Sam ^c   Mckee, William M ^d   Fritsche, Thomas R ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Northwest Pharmaceutical Res Netwk   (United States)

^d PRO West   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; IMIPENEM; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; RIFAMPICIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; FEMALE; HUMANS; IMIPENEM; INFANT; MALE; MIDDLE AGED; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; PREVALENCE; RISK FACTORS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; THIENAMYCINS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; WASHINGTON;

EID: 0032437163     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Centers for Disease Control and Prevention. Increasing pneumocoecal vaccination rates among patients of a national health-care alliance - United States, 1993. MMWR 1995; 44:741-744
2. Appelbaum PC. Antibiotic-resistanl pneumococci-facts and fiction. J Chemother 1994; 6 (Suppl 4):7-15,23-24
3. Breiman RF, Butler JC, Tenover FC, Elliot JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994; 271:1831-1835
4. Butler JC, Hofmann J, Cetron MS, Elliott JA, Facklam RR, Breiman RF. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis 1996; 174:986-993
5. Hofmann J, Cetron MS, Parley MM, Baughman WS, Facklam RR, Elliott JA, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995; 333:481-486
6. Duchin JS, Breiman RF, Diamond A, Lipman HB, Block SL, Hedrick JA, et al. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J 1995; 14:745-750
7. Collignon PJ, Bell JM. Drag-resistant Streptococcus pneumoniae: the beginning of the end for many antibiotics? Australian Group on Antimicrobial Resistance (AGAR). Med J Aust 1996; 164:64-67
8. Garcia-Martos P, Galan F, Marin P, Mira J. Increase in high resistance to penicillin of clinical isolates of Streptococcus pneumoniae in Cadiz, Spain. Chemotherapy 1997; 43:179-181
9. Baquero F, Martinez-Beltran J, Loza E. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother 1991; 28 (Suppl C):31-38
10. Levin AS, Teixeira LM, Sessegolo JF, Barone A A. Resistance of Streptococcus pneumoniae to antimicrobials in São Paulo, Brazil: clinical features and serotypes. Rev Inst Med Trop São Paulo 1996; 38:187-192
11. Pean Y, Goldstein FW, Guerrier ML. Highlights of the French Antimicrobial Resistance Surveillance Project. French Study Group. Diagn Microbiol Infect Dis 1996; 25:191-194